Bezafibrate
Sold as Sandoz bezafibrate, Bezachole sr, Bezalip, Bezalip retard
2-[4-[2-[(4-Chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid
Drag to rotate. Structure from PubChem CID 39042.
Background
Registration
- Applicants
- 3
- Registrations
- 4
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Sandoz bezafibrate 400 EACH TABLET CONTAINS BEZAFIBRATE 400 mg | 400 | 29043529/7.5/0435 | Registered | S3 | None |
| Bezachole sr EACH TABLET CONTAINS BEZAFIBRATE 400,0 mg | Not listed | 36028136/7.5/0281 | Registered | S3 | None |
| Bezalip EACH TABLET CONTAINS BEZAFIBRATE 200 mg | 200 mgTablets | Q0104Q/7.5/104Approved 8 December 2017 | Registered | S3 | PIPIL |
| Bezalip retard EACH TABLET CONTAINS BEZAFIBRATE 400 mg BEZAFIBRATE 400 mg | Not listed | S0270S/7.5/270 | Registered | S3 | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Bezafibrate
S3: Bezafibrate
Consolidated Schedules 06 July 2026, line 3219
Pharmacological class: Serum-cholesterol reducers. (class 7.5)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Bezalip, Teva Pharmaceuticals (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.